VICTOR S.
- Country
- France
- Department
- Medical Oncology
Research Overview
- PREDOSTAR - PREventing second cancers with DOSTARlimab - A multicenter, open-label, randomized phase II study aiming to assess the clinical impact of dostarlimab on occurrence of second primary cancer in patients with cured primary cancer
- Phase II Study of Ficerafusp Alfa and Nivolumab in Patients with Platinum-Refractory Head and Neck Squamous Cell Carcinoma Progressing Within 6 Months of Multimodal Therapy
- Phase I/II Open-Label Study of ALE.C04 and Pembrolizumab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Data & Insights
Has run more than one trial at 88 of 175 partner sites.
Specializations
Head and Neck Cancer Treatment
The investigator specializes in treating recurrent and metastatic head and neck squamous cell carcinoma (HNSCC), with particular emphasis on innovative therapeutic approaches.
- First-line Treatment Strategies
- Advanced Stage Disease Management
- Combination Therapy Approaches
Their research encompasses both locally advanced and metastatic disease states.
Immunotherapy Applications
Focuses on the implementation of immunotherapeutic agents in head and neck cancer treatment, particularly investigating PD-L1 positive tumors and novel antibody treatments.
- Monoclonal Antibody Therapies
- Checkpoint Inhibitor Studies
- Biomarker-Driven Treatment
Explores both monotherapy and combination approaches with immunotherapy agents.
Cancer Prevention Research
Investigates preventive strategies for second primary cancers in patients who have completed treatment for their initial cancer diagnosis.
- Post-Treatment Cancer Prevention
- Risk Reduction Strategies
- Long-term Patient Monitoring
Evaluates novel approaches to reduce cancer recurrence and secondary malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.